THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 125 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,961,599 | +78458.2% | 227,300 | -1.2% | 0.08% | -12.0% |
Q1 2023 | $2,497 | +19.5% | 230,100 | +23.5% | 0.09% | +58.6% |
Q4 2022 | $2,090 | -99.9% | 186,300 | -17.2% | 0.06% | +81.2% |
Q3 2022 | $2,282,000 | -73.3% | 225,000 | -61.7% | 0.03% | -86.5% |
Q2 2021 | $8,533,000 | +3272.7% | 587,666 | +7841.4% | 0.24% | +5825.0% |
Q3 2017 | $253,000 | -57.1% | 7,400 | -79.4% | 0.00% | -20.0% |
Q4 2015 | $590,000 | +44.3% | 35,952 | +52.5% | 0.01% | -16.7% |
Q1 2015 | $409,000 | -52.6% | 23,568 | -59.2% | 0.01% | -45.5% |
Q4 2014 | $862,000 | – | 57,773 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |